Anxiety, Depression and Quality of Life in Patients with Irritable Bowel Syndrome
1
조회
0
다운로드
10
인용
0
참고문헌
키워드
초록
Background/Aims: There have been few Asian studies regarding anxiety and depression associated with irritable bowel syndrome (IBS). The aim of this study was to evaluate the frequency and importance of anxiety and depression in Korean patients with IBS. Methods: A total of 124 IBS patients and 91 healthy subjects were enrolled consecutively. All participants were asked to complete self-administered questionnaires:one addressing symptom severity, the Short Form 36,and the Hospital Anxiety and Depression Scale (HADS). The patients were also asked to complete the IBS-specifi c quality of life (IBS–QOL) questionnaire. Results: Anxiety and depression were observed in 38.6% and 38.6% of IBS patients,respectively, and in 24.2% and 16.5% of healthy subjects, respectively (p<0.05 for both). The mean HADS scores for anxiety and depression in IBS patients were 6.8±4.5 and 7.1±4.4,respectively. Both anxiety and depression were associated with self-reported symptom severity (p<0.012 and p<0.001,respectively). As determined by multivariate analysis, symptom severity was the most important factor in the prediction of anxiety and depression. Self-reported symptom severity and depression were clearly and independently associated with the overall IBS–QOL score. Conclusions: Anxiety and depression were frequently observed in Korean IBS patients and were related to the severity of their symptoms and the impairment of the patient’s QOL. Our data suggest that assessing anxiety and depression is important when evaluating IBS patients.
Abstract
Background/Aims: There have been few Asian studies regarding anxiety and depression associated with irritable bowel syndrome (IBS). The aim of this study was to evaluate the frequency and importance of anxiety and depression in Korean patients with IBS. Methods: A total of 124 IBS patients and 91 healthy subjects were enrolled consecutively. All participants were asked to complete self-administered questionnaires:one addressing symptom severity, the Short Form 36,and the Hospital Anxiety and Depression Scale (HADS). The patients were also asked to complete the IBS-specifi c quality of life (IBS–QOL) questionnaire. Results: Anxiety and depression were observed in 38.6% and 38.6% of IBS patients,respectively, and in 24.2% and 16.5% of healthy subjects, respectively (p<0.05 for both). The mean HADS scores for anxiety and depression in IBS patients were 6.8±4.5 and 7.1±4.4,respectively. Both anxiety and depression were associated with self-reported symptom severity (p<0.012 and p<0.001,respectively). As determined by multivariate analysis, symptom severity was the most important factor in the prediction of anxiety and depression. Self-reported symptom severity and depression were clearly and independently associated with the overall IBS–QOL score. Conclusions: Anxiety and depression were frequently observed in Korean IBS patients and were related to the severity of their symptoms and the impairment of the patient’s QOL. Our data suggest that assessing anxiety and depression is important when evaluating IBS patients.
참고문헌 (42)
- Drossman DA, "AGA technical review on irritable bowel syndrome", Gastroenterology, 123, pp.2108~2131 (2002)
- Whitehead WE, "Psychologic considerations in\ the irritable bowel syndrome", Gastroenterol Clin North Am, 20, pp.249~267 (1991)
- Drossman DA, "Presidential address: gastrointestinal illness and the biopsychosocial model", Psychosom Med, 60, pp.258~267 (1998)
- Levy RL, "Psychosocial aspects of the functional gastrointestinal disorders", Gastroenterology, 130, pp.1447~1458 (2006)
- Walker EA, "Comorbidity of gastrointestinal complaints, depression, and anxiety in the Epidemiologic Catchment Area (ECA) Study", Am J Med, 92(1A), pp.26S~30S (1992)
- Drossman DA, "Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome", Am J Med, 107(5A), pp.41S~50S (1999)
- Creed F, "The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome", Gastroenterology, 124, pp.303~317 (2003)
- Drossman DA, "Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders", Gastroenterology, 125, pp.19~31 (2003)
- Vandvik PO, "Prevalence, comorbidity and impact of irritable bowel syndrome in Norway", Scand J Gastroenterol, 41, pp.650~656 (2006)
- Hillilä MT, "Comorbidity and use of health-care services among irritable bowel syndrome sufferers", Scand J Gastroenterol, 42, pp.799~806 (2007)
- Boyce PM, "A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome", Am J Gastroenterol, 98, pp.2209~2218 (2003)
- Lackner JM, "How does cognitive behavior therapy for irritable bowel syndrome work? A mediational analysis of a randomized clinical trial", Gastroenterology, 133, pp.433~444 (2007)
- Hahn BA, "Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life", Aliment Pharmacol Ther, 11, pp.553~559 (1997)
- Simrén M, "Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern", Scand J Gastroenterol, 36, pp.545~552 (2001)
- Si JM, "Irritable bowel syndrome consulters in Zhejiang province: the symptoms pattern, predominant bowel habit subgroups and quality of life", World J Gastroenterol, 10, pp.1059~1064 (2004)
- Gwee KA, "The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community", Am J Gastroenterol, 99, pp.924~931 (2004)
- Xiong LS, "A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling", Aliment Pharmacol Ther, 19, pp.1217~1224 (2004)
- Thompson WG, "Functional bowel disorders and functional abdominal pain", Gut, 45(Suppl 2), pp.II43~II47 (1995)
- Thompson WG, "Functional bowel disorders and functional abdominal pain, In Rome II: the functional gastrointestinal disorders: diagnosis, pathophysiology and treatment-- a multinational consensus. 2nd ed.", pp.351~432 (2000), Degnon Associates
- Ware JE Jr, "The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection", Med Care, 30, pp.473~483 (1992)
- Patrick DL, "Quality of life in persons with irritable bowel syndrome: development and validation of a new measure", Dig Dis Sci, 43, pp.400~411 (1998)
- Park JM, "Cross-cultural validation of Irritable Bowel Syndrome Quality of Life in Korea", Dig Dis Sci, 51, pp.1478~1484 (2006)
- Zigmond AS, "The hospital anxiety and depression scale", Acta Psychiatr Scand, 67, pp.361~370 (1983)
- Herrmann C, "International experiences with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results", J Psychosom Res, 42, pp.17~41 (1997)
- Bjelland I, "The validity of the Hospital Anxiety and Depression Scale. An updated literature review", J Psychosom Res, 52, pp.69~77 (2002)
- Oh SM, "A study on the standardization of the Hospital Anxiety and Depression Scale for Koreans: a comparison of normal, depressed and anxious groups", J Korean Neuropsychiatr Assoc, 38, pp.289~296 (1999)
- Whitehead WE, "Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications", Gastroenterology, 122, pp.1140~1156 (2002)
- Farthing MJ, "Irritable bowel, irritable body, or irritable brain", BMJ, 310, pp.171~175 (1995)
- Guthrie E, "Changes in tolerance to rectal distension correlate with changes in psychological state in patients with severe irritable bowel syndrome", Psychosom Med, 66, pp.578~582 (2004)
- Chang L, "Brain responses to visceral and somatic stimuli in irritable bowel syndrome: a central nervous system disorder", Gastroenterol Clin North Am, 34, pp.271~279 (2005)
- El-Serag HB, "Health-related quality of life among persons with irritable bowel syndrome: a systematic review", Aliment Pharmacol Ther, 16, pp.1171~1185 (2002)
- Akehurst RL, "Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting", Pharmacoeconomics, 20, pp.455~462 (2002)
- Haug TT, "Are anxiety and depression related to gastrointestinal symptoms in the general population", Scand J Gastroenterol, 37, pp.294~298 (2002)
- Drossman DA, "Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome", Gastroenterology, 95, pp.701~708 (1988)
- Creed F, "Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome", Ann Intern Med, 134(9 Pt 2), pp.860~868 (2001)
- Lee OY, "Impact of advertisement and clinic populations in symptoms and perception of irritable bowel syndrome", Aliment Pharmacol Ther, 13, pp.1631~1638 (1999)
- Naliboff BD, "Psychosocial moderators of quality of life in irritable bowel syndrome", Eur J Surg Suppl, (583), pp.57~59 (1998)
- Spiegel BM, "Clinical determinants of health-related quality of life in patients with irritable bowel syndrome", Arch Intern Med, 164, pp.1773~1780 (2004)
- Halder SL, "Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study", Aliment Pharmacol Ther, 19, pp.233~242 (2004)
- Whitehead WE, "Impact of irritable bowel syndrome on quality of life", Dig Dis Sci, 41, pp.2248~2253 (1996)
- Schmulson M, "Symptom differences in moderate to severe IBS patients based on predominant bowel habit", Am J Gastroenterol, 94, pp.2929~2935 (1999)
- American Gastroenterology Association, "American Gastroenterological Association medical position statement: irritable bowel syndrome", Gastroenterology, 123, pp.2105~2107 (2002)
